Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections.
Pier Giorgio CojuttiSara TedeschiEleonora ZampariniPierluigi VialeFederico PeaPublished in: Clinical pharmacokinetics (2024)
A decrease in C-RP is related to dalbavancin exposure in osteoarticular infections. Targeting dalbavancin plasma concentrations above the efficacy threshold may be associated with effective treatment.